EUVIMEDEUVIMED entdecken
Open Access

Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐162)

EFSA Panel on Genetically Modified Organisms (GMO), Josep Casacuberta, Francisco Barro, Albert Braeuning, Pilar Cubas, Ruud de Maagd, Michelle M Epstein, Thomas Frenzel, Jean-Luc Gallois, Frits Koning, Antoine Messéan, F Javier Moreno und 14 weitere

EFSA Journal · 2024-11 · 22 (11)

DOI: 10.2903/j.efsa.2024.9060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EFSA Journal, 2024-11. Verfasst von EFSA Panel on Genetically Modified Organisms (GMO) und 25 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetically modified Komagataella phaffii strain MXY0541 was developed to produce soy leghemoglobin by introducing the LGB2 coding sequence encoding leghemoglobin from soybean (Glycine max). The molecular characterisation data and bioinformatic analyses do not raise any safety concerns. The safety of soy leghemoglobin as a food additive has already been assessed by the EFSA FAF Panel (EFSA‐Q‐2022‐00031). The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of soy leghemoglobin protein as expressed in K. phaffii, and finds no evidence that the genetic modification would change its overall allergenicity. The GMO Panel concludes that the LegH Prep derived from genetically modified K. phaffii strain MXY0541 is safe for human consumption with regard to the effects of the genetic modification. No environmental impact from the use of this product is expected regarding the recombinant DNA sequences possibly remaining in the product. The GMO Panel concludes that LegH Prep from genetically modified K. phaffii strain MXY0541 is safe with respect to potential effects on human health and the environment at the proposed use and use level as far as the impact of the genetic modification is concerned. The overall conclusion is that the genetic modification does not lead to safety issues.

Schlagwörter

Stichwörter der Autor:innen

food colourgenetically modified Komagataella phaffiimeat analogue productssoy leghemoglobin

Zitieren

APA

EFSA Panel on Genetically Modified Organisms (GMO), Casacuberta, J., Barro, F., Braeuning, A., Cubas, P., de Maagd, R., Epstein, M. M., Frenzel, T., Gallois, J. L., Koning, F., Messéan, A., Moreno, F. J., Nogué, F., Savoini, G., Schulman, A. H., Tebbe, C., Veromann, E., Gennaro, A., Gil Gonzalez, A. B., …, & Schoonjans, R. (2024). Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐162). EFSA Journal, 22(11). https://doi.org/10.2903/j.efsa.2024.9060

Vancouver

EFSA Panel on Genetically Modified Organisms (GMO), Casacuberta J, Barro F, Braeuning A, Cubas P, de Maagd R, et al. Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐162). EFSA Journal. 2024;22(11). doi:10.2903/j.efsa.2024.9060

BibTeX
@article{EFSAPanelonGeneticallyModifiedOrganismsGMO2024,
  author = {EFSA Panel on Genetically Modified Organisms (GMO), EFSA Panel on Genetically Modified Organisms (GMO) and Casacuberta, Josep and Barro, Francisco and Braeuning, Albert and Cubas, Pilar and de Maagd, Ruud and Epstein, Michelle M and Frenzel, Thomas and Gallois, Jean-Luc and Koning, Frits and Messéan, Antoine and Moreno, F Javier and Nogué, Fabien and Savoini, Giovanni and Schulman, Alan H and Tebbe, Christoph and Veromann, Eve and Gennaro, Andrea and Gil Gonzalez, Aina Belen and Gómez Ruiz, José Ángel and Goumperis, Tilemachos and Kagkli, Dafni Maria and Lenzi, Paolo and Lewandowska, Aleksandra and Piffanelli, Pietro and Schoonjans, Reinhilde},
  title = {Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐162)},
  journal = {EFSA Journal},
  year = {2024},
  volume = {22},
  number = {11},
  doi = {10.2903/j.efsa.2024.9060}
}
Kostenlos starten →